Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (211-220 of 459) with videos related to

Pageof 46
Sort By:
Cancers|June 10, 2022
Unveiling the Molecular Mechanisms Driving the Capsaicin-Induced Immunomodulatory Effects on PD-L1 Expression in Bladder and Renal Cancer Cell LinesMaria Beatrice Morelli, Oliviero Marinelli, Cristina Aguzzi, et al.
Cancer Metastasis Reviews|September 14, 2015
The origin of prostate metastases: emerging insightsMatteo Santoni, Francesco Piva, Marina Scarpelli, et al.
International Journal of Cancer|February 7, 2026
International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and PortugalJose C Tapia, Javier Gavira, Diana Matthews, et al.
Current Drug Targets|February 6, 2015
Bladder cancer: molecular determinants of personalized therapyAntonio Lopez-Beltran, Matteo Santoni, Francesco Massari, et al.
International Journal of Molecular Sciences|November 27, 2019
The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological ImplicationsGaetano Aurilio, Francesco Piva, Matteo Santoni, et al.
Critical Reviews in Oncology/Hematology|August 25, 2014
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinomaFancesco Maria Guida, Matteo Santoni, Alessandro Conti, et al.
Frontiers in Oncology|November 20, 2018
The Identification of Immunological Biomarkers in Kidney CancersAntonio Lopez-Beltran, Vanessa Henriques, Alessia Cimadamore, et al.
Clinical & Experimental Metastasis|December 31, 2024
Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 studyAlessandro Rizzo, Fernando Sabino Marques Monteiro, Veronica Mollica, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 12, 2017
Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agentsMatteo Santoni, Emanuela Romagnoli, Tiziana Saladino, et al.
Future Oncology (London, England)|November 10, 2018
Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back?Vincenzo Di Nunno, Lidia Gatto, Benedetta Fragomeno, et al.
Pageof 46

Showing results (211-220 of 459) with videos related to

Sort By:
Pageof 46
Cancers|June 10, 2022
Unveiling the Molecular Mechanisms Driving the Capsaicin-Induced Immunomodulatory Effects on PD-L1 Expression in Bladder and Renal Cancer Cell LinesMaria Beatrice Morelli, Oliviero Marinelli, Cristina Aguzzi, et al.
Cancer Metastasis Reviews|September 14, 2015
The origin of prostate metastases: emerging insightsMatteo Santoni, Francesco Piva, Marina Scarpelli, et al.
International Journal of Cancer|February 7, 2026
International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and PortugalJose C Tapia, Javier Gavira, Diana Matthews, et al.
Current Drug Targets|February 6, 2015
Bladder cancer: molecular determinants of personalized therapyAntonio Lopez-Beltran, Matteo Santoni, Francesco Massari, et al.
International Journal of Molecular Sciences|November 27, 2019
The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological ImplicationsGaetano Aurilio, Francesco Piva, Matteo Santoni, et al.
Critical Reviews in Oncology/Hematology|August 25, 2014
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinomaFancesco Maria Guida, Matteo Santoni, Alessandro Conti, et al.
Frontiers in Oncology|November 20, 2018
The Identification of Immunological Biomarkers in Kidney CancersAntonio Lopez-Beltran, Vanessa Henriques, Alessia Cimadamore, et al.
Clinical & Experimental Metastasis|December 31, 2024
Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 studyAlessandro Rizzo, Fernando Sabino Marques Monteiro, Veronica Mollica, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 12, 2017
Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agentsMatteo Santoni, Emanuela Romagnoli, Tiziana Saladino, et al.
Future Oncology (London, England)|November 10, 2018
Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back?Vincenzo Di Nunno, Lidia Gatto, Benedetta Fragomeno, et al.
Pageof 46